William S. Marth
About William S. Marth
Career at Teva Pharmaceutical Industries
William S. Marth served as the President and CEO of Teva Pharmaceutical Industries Ltd. for the Americas. He was also a member of Teva's global executive management team from 2007 to 2012. During his tenure, he played a crucial role in steering the company's operations in the Americas. Prior to his executive role, Marth served as Executive Vice President and Vice President of sales and marketing for Teva USA. His extensive experience at Teva significantly contributed to the company's market presence and operational efficiency.
President of Services at Curia
William S. Marth is currently the President of Services at Curia, previously known as AMRI. He was instrumental in leading the take-private transaction of AMRI, which was valued at $1.6 billion. His leadership in this significant financial undertaking highlights his expertise in managing high-stakes corporate transactions and strategic business transformations.
Education and Scholarly Recognition
William S. Marth earned his bachelor's degree in pharmacy from the University of Illinois. He furthered his education by earning an MBA from the Keller Graduate School of Management, DeVry University. In recognition of his contributions to the field, he received an honorary Doctor of Humane Letters (D.H.L.) from the Albany College of Pharmacy and Health Sciences. His educational background and scholarly recognition underscore his deep understanding of both pharmaceutical sciences and business management.
Board Memberships and Advisory Roles
William S. Marth has held numerous significant board positions and advisory roles. He served as the Chairman of the Board for Sorrento Biotherapeutics and as an Independent Director at Galmed and Teligent. Additionally, he was the Chairman of the board of the Generic Pharmaceutical Association (currently AAM) and served on the Board of the American Society for Health-System Pharmacists. He is currently an NED at Rosemont Pharmaceuticals Ltd. in the UK and serves on the Advisory Board of Lupin Pharmaceuticals. Marth also contributes to various non-profit boards, reflecting his broad influence and commitment to the pharmaceutical industry.
Executive Roles with Emcure Pharmaceutical Company
William S. Marth served as the Global President and Chief Executive Officer of North America and Europe for Emcure Pharmaceutical Company until December 2021. In this role, he oversaw the company's operations across significant international markets. His leadership at Emcure exemplifies his ability to manage and expand pharmaceutical enterprises on a global scale.